Demodicose canina Canine demodicosis - Faculdade de Medicina ...

Leitão JPA e Leitão JPA RPCV (2008) 103 (567-568) 135-149
Bibliografia
Adams HR (2001). Section 11 – Chemotherapy of parasitic
diseases. Chapter 50 – Ectoparasiticides. In: Veterinary
Pharmacology and Therapeutics. 8 th Edition, Blackwell
Publishing (Iowa), 1025: 1029-1030.
Bayer HealthCare – Divisão Saúde Animal (2003). Manual
Técnico Advocate – O Endectocida.
Bensignor E (2002). Comparison of skin scrapings,
thricograms and skin surface biopsy for the diagnosis of
demodicosis in dogs. Proceedings of the 18º Annual
Congress of the European Society Veterinary
Dermatology and European College of Veterinary
Dermatology (Nice).
Bettenay SV e Hargis AM (2006). Section 3 –
Histopathologic responses of the skin to injurie. In:
Practical Veterinary Dermatopathology. 1st Edition, Teton
NewMedia, 99-101.
Bonagura JD e Twedt DC (2009). Section V – Dermatologic
diseases. Chapter 86 – Avermectins in dermatology. In:
Kirk’s Current Veterinary Therapy. 14 th Edition, W. B.
Saunders Company (Missouri), 390-394.
Booth NH e McDonald LE (1998). Capítulo 4 – Agentes
Tópicos, Secção 12: Drogas de Ação Local na Pele, nas
Mucosas, Olhos e Ouvidos. In: Farmacologia e terapêutica
em veterinária. 6ª Edição, Guanabara Koogan, 592-593.
Dicato M, Duhem C, Pauley M e Ries F (1997). Multidrug
resistance: Molecular and clinical aspects. Cytokines Cell
Molecular Therapy, 3(2): 91-99.
Ferrer L (1997). Sarna demodecica. Proceedings da 8º
Educação Continua da Associação Portuguesa de Médicos
Veterinários Especialistas em Animais de Companhia
(Estoril).
Garfield RA, Reedy LM (1992). The use of oral
milbemycin oxime (Interceptor) in the treatment of
chronic generalized canine demodicosis. Veterinary
Dermatology, 3: 231-235.
González FP, Barroso FP, Maseda FD e Padrón PF (1998).
Un caso de demodicosis canina – Prueba sobre la eficacia
de la moxidectina oral. Consulta de Difusión Veterinária,
6(52): 1870-1871.
Griffin CE, Kwochka KW e MacDonald JM
(1993). Demodicosis. In: Current Veterinary Dermatology
– The Science and Art of Therapy. 1ª Ed., Mosby (USA),
72-84.
Gross TL, Ihrke PJ, Walder EJ e Affolter VK (2005). Chapter
17 – Pustular and nodular diseases with adnexal destruction.
Canine Demodicosis. In: Skin Diseases of the Dog
and Cat – Clinical and histopathologic diagnosis. 2 nd
Edition, Blackwell Publishing, 442-447.
Guaguère E (1991). La démodécie du chien adult a propos
de 22 cas. Pratique Mèdicale et Chirurgicale de l’animal
de compagnie, 26(5): 411-419.
Guaguère E (1996). Traitement de la démodécie généralisée
du chien par l’ivermectine: à propos de 20 cas. Pratique
Mèdicale et Chirurgicale de l’Animal de Compagnie, 31:
33-40.
Hill PB (2002). Small Animal Dermatology – A practical
148
guide to the diagnosis and management of skin diseases in
dogs and cats. Butterworth-Heinemann, 6-9 e 270-274.
Hillier A, Foster AP e Kwochka KW (2004). Parasites
and antiparasitic drugs. Demodicosis. In: Advances in
Veterinary Dermatology, Volume 5. 5 th Edition, Blackwell
Publishing (Vienna), 300-305.
Hugnet C, Bruchon-Hugnet C, Royer H e Bourdoiseau G
(2001). Efficacy of 1.25% amitraz solution in the
treatment of generalized demodicosis (eight cases) and
sarcoptic mange (five cases) in dogs. Veterinary
Dermatology, 12: 89-92.
Hugnet C, Burunfosse F, Pineau X, Cadoré JL, Longue G e
Berny PJ (1996). Toxicity and kinetics of amitraz in dogs.
American Journal of Veterinary Research, 57(10):
1506-1510.
I & D – Departamento de Investigação e Desenvolvimento
da Calier SA (2006). Infermun® na Demodicose Canina,
Calier.
Knottenbelt MK (1994). Chronic otitis-externa due to
Demodex canis in a Tibetan spaniel. The Veterinary
Record, 135(17): 409-410.
Kwochka KW, Willemse T e von Tscharner C (1998).
Advances in Veterinary Dermatology. Butter-Heinemann
(Oxford), 552-584.
Leitão JPA e Oliveira AM (2003). Demodecose Canina. O
Médico Veterinário, 77: 46-55.
Lopez JR (1998). Tratamiento de la sarna demodecica
generalizada: novedades. Consulta de Difusion
Veterinaria, 6: 1198-1199.
Margo K (2007). Predisposição genética para reacções
adversas a medicamentos no cão. Veterinary Focus, 17(2):
11-17.
Mathet JL, Bensignor E e Segault P (1996). La démodécie
canine: actualités. Recueil de Médecine Vétérinaire, 172:
149-165.
Mealey KL, Bentjen SA, Gay J e Cantor GH (2001).
Ivermectin sensitivity in collies is associated with a deletion
mutation of the mdr1 gene. Pharmacogenetics, 11(8):
727-733.
Mealey KL, Bentjen SA e Waiting D (2002). Frequency of
the mutant MDR1 alel associated with ivermectin
sensitivity in a sample population of collies from the
northwestern United States. American Journal of
Veterinary Research, 63(4): 479-481.
Medleau L, Hnilica A (2006). Chapter 5 – Parasitic skin
disorders. In: Small Animal Dermatology – A Color Atlas
and Therapeutic Guide. 2 nd Edition, Saunders Elsevier;
102-108.
Medleau L, Ristic Z e Mcelveen DR (1996). Daily
ivermectin for treatment of generalized demodicosis in
dogs. Veterinary Dermatology, 7: 209-212.
Medleau L e Willemse T (1995). Efficacy of daily amitraz
therapy for refractory generalized demodicosis in dogs:
two independent studies. Journal of the American Animal
Hospital Association, 31(3): 246-249.
Mueller RS (2000). Specific tests in small animal dermatology.
In: Dermatology for the Small Animal Practitionier.
1 st Edition, Tenton NewMedia, 28-30 e 36-38.